Magnolia Diagnostics, LLC

Magnolia Diagnostics, LLC was paid $3.68M by Medicaid between Jan 2019 and Apr 2024, across 20 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 41% of everything it billed.

Compared with peers

Next to other Clinical Pathology/Laboratory Medicine Physician providers in Texas

Rank by total paid#1 of 10

Median peer was paid$116K

This provider vs. median32×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2019	6,326	$466K
2020	20,063	$198K
2021	53,653	$1.23M
2022	40,222	$1.35M
2023	12,213	$406K
2024incomplete	744	$32K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	41%	26,907	20,434	$1.51M
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	19%	5,280	4,786	$700K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	11%	21,567	17,613	$390K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	5.7%	20,895	7,178	$208K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	4.9%	13,909	6,382	$180K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	4.0%	6,197	5,217	$145K
87631		2.6%	2,616	1,989	$96K
87486		1.9%	6,249	5,260	$71K
87640		1.8%	6,432	5,409	$67K
87581		1.8%	5,892	4,966	$65K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.7%	945	879	$61K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	1.6%	6,669	5,558	$58K

8 more codes

87541		1.5%	5,851	$56K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,429	$32K
87582		<1%	330	$15K
87542		<1%	330	$15K
87506		<1%	42	$3K
87150		<1%	666	$1K
87634		<1%	913	$65.51
87481		0%	102	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBAINS, JOHN (PRESIDENT)

Parent organizationMAGNOLIA HEALTH, LLC